X-Chem is the partner that empowers you to rapidly screen billions of drug-like compounds against your target with our groundbreaking DNA-encoded library (DEL) screening platform. Because our experts pioneered DEL-driven drug discovery, we can help you leverage our market-leading platform and profoundly diverse chemical libraries with unprecedented speed and clarity.

Working with a variety of clients, including 10 of the top 20 pharma companies, our success rate in identifying functional hits against challenging targets is 80%. The versatile X-Chem drug discovery engine has identified potent hits in 30+ target classes. These compounds blend desired selectivities and modes of action with attractive physicochemical properties. We have licensed 85+ programs with anticipated expansion year over year.